The New York Stock Exchange (NYSE) has spent about a year testing Avalanche blockchain technology as it develops infrastructure for a tokenized securities platform. The platform aims to support tokenized U.S. stocks and ETFs with blockchain-based settlement, pending regulatory approval. NYSE has built a close working relationship with Ava Labs, the developer of Avalanche, but has not yet selected a blockchain for its system, which is designed to work with multiple networks. The project includes features like continuous trading, immediate settlement, fractional shares, and stablecoin funding, and is part of a broader move by NYSE's parent company, Intercontinental Exchange (ICE), to build tokenized securities infrastructure with partners like tZERO and Securitize. Recent SEC exemptions for tokenized stock trading could accelerate market adoption, though major exchanges' timelines remain uncertain.
The New York Stock Exchange's year-long testing of Avalanche technology is notable context for readers. For those tracking major cryptocurrencies on Pluang, 46 of 50 rose today. Notable movers include DOT at Rp20.185 with a 9.96% increase and 75% buy order activity, ONE at Rp31 with a 9.17% rise but 98% sell orders, and ETC at Rp143.151 up 9.00% with 99% buy orders. This data is as of Sep 18, 2026 21:36 WIB.
Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...
Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...
Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...
Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...
iShares Semiconductor ETF and VanEck Semiconductor ETF are recommended as strong buys due to robust capital investment driven by AI infrastructure and sector demand outpacing the broader market. The AI buildout is attracting unprecedented capital int...
